Immunomic Therapeutics, Inc.
New Filing
CIK: 0001543256·Biotechnology·DELAWARE·Filed: Apr 10, 2024
Total Offering
$20,900,000
Amount Sold
$3,000,000
Investors
1
First Sale
Jan 30, 2024
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Dong-Gun Kim | Related Person |
| C. ERIC WINZER | Related Person |
| Robert Ahlgren | Related Person |
| Steve Park | Related Person |
| Ki-Hong Ahn | Related Person |
| Matthew Chang | Related Person |
| Michael Lack | Related Person |
| Ronald Thiboutot | Related Person |
| James Wishart | Related Person |
| Yang Gon Jin | Related Person |
Company
Immunomic Therapeutics, Inc.
ATTN: C. Eric Winze, 15010 BROSCHART RD.
ROCKVILLE, MD, 20850
301-968-3509
SEC Filing
0001543256-24-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free